The National Horseracing Authority of Southern Africa (the NHA) confirms reported Prohibited Substance findings from Out-of-competition Specimen Collection. 

1. The presence of Flunixin, a non-steroidal anti-inflammatory drug (NSAID) classified as a Class 4 prohibited substance, was disclosed upon analysis of a specimen taken from RED SEA HILLS at the Vaal Racecourse Training Centre on 12 June 2025.  The Trainer responsible, Mr J H Borman, elected to sign an Admission of Guilt for a contravention of Rules 73.2.7 and 10.5.14, and a fine for an amount of R18 000 was imposed. 

1. The presence of Flunixin, a non-steroidal anti-inflammatory drug (NSAID) classified as a Class 4 prohibited substance, was disclosed upon analysis of a specimen taken from FIRE ‘N FLAMES at the Vaal Racecourse Training Centre on 12 June 2025.  The Trainer responsible, Mr J S Roux, elected to sign an Admission of Guilt for a contravention of Rules 73.2.7 and 10.5.14, and a fine for an amount of R18 000 was imposed. 

Flunixin meglumine is commonly used in horses to reduce pain, inflammation, and fever, particularly in cases of musculoskeletal injury or colic. While safe and effective when used under veterinary supervision, its administration is prohibited within certain periods prior to racing and must be accurately recorded in the Veterinary Treatment Register (VTR).  

In determining the above penalties, careful consideration was given to the class of substance involved, the Trainers’ records of prior prohibited substance contraventions within the past five years, the concentration of the substance detected in the specimen, and whether there was adequate compliance with the Veterinary Treatment Register (VTR). 

A D Hyde

Racing Control Executive